retatrutide mechanism of action triple agonist glp-1 gip glucagon Retatrutide—A Game Changer in Obesity Pharmacotherapy Mechanisms of action of GLP-1RA.
Description
The region benefits from high healthcare expenditure and widespread awareness about obesity-related health risks
Nat Commun (2015) 6:6934
Rest of Africa 19.4
IH has received grants from AstraZeneca/Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, Lexicon Pharmaceuticals, Medtronic, Merck & Co., Novo Nordisk, the Population Health Research Institute and Sanofi
